All County Health Care wants to welcome and thank Dr. James Galvin from the UMIAMI Miller School of Medicine Comprehensive Center for Brain Health located in Boca Raton
Watch the episode here:...Dr. James E. Galvin Shares with Scripps News A New Tool Developed By Researchers Could Be Breakthrough Assessing Alzheimer’s Risk
Addressing Unmet Needs of Dementia With Lewy Bodies: James Galvin, MD, MPH
Watch Here: https://www.neurologylive.com/view/addressing-unmet-needs-dementia-with-lewy-bodies-james-galvin
Digital brain health platform offers rapid, accurate assessment of dementia risk
Click here to learn more: https://www.healio.com/news/neurology/20221117/digital-brain-health-platform-offers-rapid-accurate-assessment-of-dementia-risk
Efe News/Yahoo Noticias!
Científicos estadounidenses han implementado un nuevo programa de salud que proporciona herramientas para evaluar con precisión el riesgo de que un paciente desarrolle Alzheimer y otras afecciones neurológicas, informó este miércoles la Facultad de Medicina Miller de...
Listen to this podcast: Dying To Remember
Researchers at the Miller School of Medicine are testing a new drug for dementia with Lewy bodies, a disease that affects an estimated 1.4 million Americans. James Galvin, M.D., M.P.H., director of the Comprehensive Center for Brain Health at the Miller School,...
Study: New Brain Health Platform Gives Physicians New Tools to Precisely Assess Dementia Risk
Read the article here: https://physician-news.umiamihealth.org/study-new-brain-health-platform-gives-physicians-new-tools-to-precisely-assess-dementia-risk/
Exploring Ties Between COVID and Alzheimer’s Disease
The COVID symptom known as “brain fog” can be frustrating and disruptive to daily life. The good news: post-COVID brain fog isn’t permanent. However, there’s reason to think COVID-19 may cause blood vessel changes related to brain disease. Neurologists and...